164 related articles for article (PubMed ID: 35646380)
21. The use of telecommunication and virtualization among ongoing and discontinued COVID-19 clinical trials: A cross-sectional analysis.
Greenough MC; Sajjadi NB; Rucker B; Vassar M; Hartwell M
Contemp Clin Trials; 2022 Mar; 114():106681. PubMed ID: 35045363
[TBL] [Abstract][Full Text] [Related]
22. Virtual educational meetings and activities during the COVID-19 pandemic and beyond: Egyptian oncologists' experience.
Alorabi M; Abdelhafiz AS; Mostafa N; Ali A; Elghazawy H; Mesbah A; Jazieh AR
Ecancermedicalscience; 2021; 15():1275. PubMed ID: 34567260
[TBL] [Abstract][Full Text] [Related]
23. A National Survey of Radiation Oncology Experiences Completing Tele-Consultations During the Coronavirus Disease (COVID-19) Pandemic.
Chhabra AM; Chowdhary M; Choi JI; Hasan S; Press RH; Simone CB
Adv Radiat Oncol; 2021; 6(1):100611. PubMed ID: 33458451
[TBL] [Abstract][Full Text] [Related]
24. Virtual Management of Patients With Cancer During the COVID-19 Pandemic: Web-Based Questionnaire Study.
Tashkandi E; Zeeneldin A; AlAbdulwahab A; Elemam O; Elsamany S; Jastaniah W; Abdullah S; Alfayez M; Jazieh AR; Al-Shamsi HO
J Med Internet Res; 2020 Jun; 22(6):e19691. PubMed ID: 32501807
[TBL] [Abstract][Full Text] [Related]
25. Impact of the COVID-19 Pandemic on Breast Cancer Management in Portugal: A Cross-Sectional Survey-Based Study of Medical Oncologists.
Alpuim Costa D; Nobre JGG; Fernandes JP; Batista MV; Simas A; Sales C; Gouveia H; Ribeiro LA; Coelho A; Brito M; Inácio M; Cruz A; Mariano M; Savva-Bordalo J; Fernandes R; Oliveira A; Chaves A; Fontes-Sousa M; Sampaio-Alves M; Martins-Branco D; Afonso N
Oncol Ther; 2022 Jun; 10(1):225-240. PubMed ID: 35312952
[TBL] [Abstract][Full Text] [Related]
26. It is unprecedented: trial management during the COVID-19 pandemic and beyond.
Mitchell EJ; Ahmed K; Breeman S; Cotton S; Constable L; Ferry G; Goodman K; Hickey H; Meakin G; Mironov K; Quann N; Wakefield N; McDonald A
Trials; 2020 Sep; 21(1):784. PubMed ID: 32917258
[TBL] [Abstract][Full Text] [Related]
27. Perspectives on Oncology-Specific Language During the Coronavirus Disease 2019 Pandemic: A Qualitative Study.
Gharzai LA; Resnicow K; An LC; Jagsi R
JAMA Oncol; 2020 Sep; 6(9):1424-1428. PubMed ID: 32761102
[TBL] [Abstract][Full Text] [Related]
28. Conducting a supportive oncology clinical trial during the COVID-19 pandemic: challenges and strategies.
Deng J; Lukens JN; Cohn JC; McMenamin E; Murphy B; Spinelli BA; Murphy N; Steinmetz AK; Landriau MA; Lin A
Trials; 2022 Nov; 23(1):927. PubMed ID: 36348346
[TBL] [Abstract][Full Text] [Related]
29. COVID-19 and the acceleration toward remote cancer care.
Wix SN; Nieva JJ
Proc (Bayl Univ Med Cent); 2022; 35(2):259-260. PubMed ID: 35261474
[TBL] [Abstract][Full Text] [Related]
30. Opportunities and Challenges for Decentralized Clinical Trials: European Regulators' Perspective.
de Jong AJ; van Rijssel TI; Zuidgeest MGP; van Thiel GJMW; Askin S; Fons-Martínez J; De Smedt T; de Boer A; Santa-Ana-Tellez Y; Gardarsdottir H;
Clin Pharmacol Ther; 2022 Aug; 112(2):344-352. PubMed ID: 35488483
[TBL] [Abstract][Full Text] [Related]
31. Mental Health Clinical Research Innovations during the COVID-19 Pandemic: The Future Is Now.
Ahern KB; Lenze EJ
Psychiatr Clin North Am; 2022 Mar; 45(1):179-189. PubMed ID: 35219437
[TBL] [Abstract][Full Text] [Related]
32. Participant Experiences of a COVID-19 Virtual Clinical Study Using the Current Health Remote Monitoring Platform: Case Study and Qualitative Analysis.
Pugmire J; Lever Taylor J; Wilkes M; Wolfberg A; Zahradka N
JMIR Form Res; 2022 Jul; 6(7):e37567. PubMed ID: 35671408
[TBL] [Abstract][Full Text] [Related]
33. Multiple Sclerosis Patient Management During the COVID-19 Pandemic: Practical Recommendations From the Portuguese Multiple Sclerosis Study Group (GEEM).
Cerqueira JJ; Ladeira AF; Silva AM; Timóteo Â; Vale J; Sousa L; Arenga M; Abreu P; Guerreiro R; de Sá J
Front Neurol; 2021; 12():613769. PubMed ID: 33790847
[TBL] [Abstract][Full Text] [Related]
34. The impact of COVID-19 on otolaryngology research: a cross-sectional analysis of discontinued trials.
Rucker BM; Sajjadi NB; Brame LS; Vassar M; Hartwell ML
J Osteopath Med; 2022 Apr; 122(8):393-399. PubMed ID: 35363445
[TBL] [Abstract][Full Text] [Related]
35. Trial of Early Antiviral Therapies during Non-hospitalized Outpatient Window (TREAT NOW) for COVID-19: a summary of the protocol and analysis plan for a decentralized randomized controlled trial.
Kaizer AM; Wild J; Lindsell CJ; Rice TW; Self WH; Brown S; Thompson BT; Hart KW; Smith C; Pulia MS; Shapiro NI; Ginde AA
Trials; 2022 Apr; 23(1):273. PubMed ID: 35395957
[TBL] [Abstract][Full Text] [Related]
36. Management of patients with cancer during the COVID-19 pandemic: The Italian perspective on the second wave.
Indini A; Pinotti G; Artioli F; Aschele C; Bernardi D; Butera A; Defraia E; Fasola G; Gamucci T; Giordano M; Iaria A; Leo S; Ribecco AS; Rossetti R; Savastano C; Schena M; Silva RR; Grossi F; Blasi L
Eur J Cancer; 2021 May; 148():112-116. PubMed ID: 33743478
[TBL] [Abstract][Full Text] [Related]
37. Drug Information Association (DIA) 2021 Global Annual Meeting (June 26-July 1, 2021 - Virtual Meeting).
Kaur R
Drugs Today (Barc); 2021 Oct; 57(10):631-637. PubMed ID: 34713871
[TBL] [Abstract][Full Text] [Related]
38. Increasing the efficiency of trial-patient matching: automated clinical trial eligibility pre-screening for pediatric oncology patients.
Ni Y; Wright J; Perentesis J; Lingren T; Deleger L; Kaiser M; Kohane I; Solti I
BMC Med Inform Decis Mak; 2015 Apr; 15():28. PubMed ID: 25881112
[TBL] [Abstract][Full Text] [Related]
39. Impact of COVID-19 on social media as perceived by the oncology community: results from a survey in collaboration with the European Society for Medical Oncology (ESMO) and the OncoAlert Network.
Morgan G; Tagliamento M; Lambertini M; Devnani B; Westphalen B; Dienstmann R; Bozovic-Spasojevic I; Calles A; Criscitiello C; Curioni A; Garcia AM; Lamarca A; Pilotto S; Scheffler M; Strijbos M; Wong R; de Azambuja E; Peters S
ESMO Open; 2021 Apr; 6(2):100104. PubMed ID: 33838532
[TBL] [Abstract][Full Text] [Related]
40. Leveraging patient-centric sampling for clinical drug development and decentralized clinical trials: Promise to reality.
Maass KF; Barfield MD; Ito M; James CA; Kavetska O; Kozinn M; Kumar P; Lepak M; Leuthold LA; Li W; Mikhailov D; Patel S; Perez NL; Jackson Rudd D; Vakkalagadda B; Williams TM; Zha J; Zhang X; Anderson MD
Clin Transl Sci; 2022 Dec; 15(12):2785-2795. PubMed ID: 36129129
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
